Literature DB >> 29504408

Aging With Down Syndrome: The Dual Diagnosis: Alzheimer's Disease and Down Syndrome.

Gabriele Cipriani1,2, Sabrina Danti3, Cecilia Carlesi1, Mario Di Fiorino2.   

Abstract

BACKGROUND: People with Down syndrome (DS) enjoy a longer life expectancy now than they ever have before and are therefore at greater risk of developing conditions associated with aging, including dementia.
OBJECTIVES: To explore the phenomenon of dementia in DS.
METHODS: Medline and Google Scholar searches were conducted for relevant articles, chapters, and books published until 2017. Search terms included Alzheimer's disease, cognitive impairment, dementia, DS, and trisomy 21. Publications found through this indexed search were reviewed for further references. RESULTS AND
CONCLUSIONS: Virtually, all subject aged 35 to 40 show key neuropathologic changes characteristic of Alzheimer's disease, but only a part of them show clinical signs of dementia, usually around the age of 50 years. Early signs of dementia in people with DS may be different from those experienced by the general population. Failure to recognize this can delay diagnosis and subsequent interventions.

Entities:  

Keywords:  Alzheimer’s disease; Down syndrome; cognitive impairment; dementia; trisomy 21

Mesh:

Year:  2018        PMID: 29504408     DOI: 10.1177/1533317518761093

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  5 in total

Review 1.  Targeting Mitochondrial Network Architecture in Down Syndrome and Aging.

Authors:  Nunzia Mollo; Rita Cicatiello; Miriam Aurilia; Roberta Scognamiglio; Rita Genesio; Maria Charalambous; Simona Paladino; Anna Conti; Lucio Nitsch; Antonella Izzo
Journal:  Int J Mol Sci       Date:  2020-04-29       Impact factor: 5.923

2.  Development of a symptom menu to facilitate Goal Attainment Scaling in adults with Down syndrome-associated Alzheimer's disease: a qualitative study to identify meaningful symptoms.

Authors:  Kari Knox; Justin Stanley; James A Hendrix; Hampus Hillerstrom; Taylor Dunn; Jillian Achenbach; Brian A Chicoine; Florence Lai; Ira Lott; Sanja Stanojevic; Susan E Howlett; Kenneth Rockwood
Journal:  J Patient Rep Outcomes       Date:  2021-01-11

3.  Cerebellar Calcium-Binding Protein and Neurotrophin Receptor Defects in Down Syndrome and Alzheimer's Disease.

Authors:  Jennifer C Miguel; Sylvia E Perez; Michael Malek-Ahmadi; Elliott J Mufson
Journal:  Front Aging Neurosci       Date:  2021-03-12       Impact factor: 5.750

4.  Executive Functioning in Adults with Down Syndrome: Machine-Learning-Based Prediction of Inhibitory Capacity.

Authors:  Mario Fernando Jojoa-Acosta; Sara Signo-Miguel; Maria Begoña Garcia-Zapirain; Mercè Gimeno-Santos; Amaia Méndez-Zorrilla; Chandan J Vaidya; Marta Molins-Sauri; Myriam Guerra-Balic; Olga Bruna-Rabassa
Journal:  Int J Environ Res Public Health       Date:  2021-10-14       Impact factor: 3.390

5.  Cognitive Function during the Prodromal Stage of Alzheimer's Disease in Down Syndrome: Comparing Models.

Authors:  Christy L Hom; Katharine A Kirby; Joni Ricks-Oddie; David B Keator; Sharon J Krinsky-McHale; Margaret B Pulsifer; Herminia Diana Rosas; Florence Lai; Nicole Schupf; Ira T Lott; Wayne Silverman
Journal:  Brain Sci       Date:  2021-09-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.